96 related articles for article (PubMed ID: 31786304)
1. Prostate Cancer in Men With Treated Advanced Heart Failure: Should we Keep Screening?
Lee HH; Shaw NM; Mohammed S; Kowalczyk KJ; Stamatakis L; Krasnow RE
Urology; 2020 Feb; 136():46-50. PubMed ID: 31786304
[TBL] [Abstract][Full Text] [Related]
2. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
[TBL] [Abstract][Full Text] [Related]
3. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
4. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
[TBL] [Abstract][Full Text] [Related]
5. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
6. Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome.
Takeda K; Takayama H; Colombo PC; Jorde UP; Yuzefpolskaya M; Fukuhara S; Mancini DM; Naka Y
J Heart Lung Transplant; 2015 May; 34(5):667-74. PubMed ID: 25577566
[TBL] [Abstract][Full Text] [Related]
7. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
[TBL] [Abstract][Full Text] [Related]
8. Does renal dysfunction and method of bridging support influence heart transplant graft survival?
Haglund NA; Feurer ID; Dwyer JP; Stulak JM; DiSalvo TG; Keebler ME; Schlendorf KH; Wigger MA; Maltais S
Ann Thorac Surg; 2014 Sep; 98(3):835-41. PubMed ID: 25069689
[TBL] [Abstract][Full Text] [Related]
9. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
[TBL] [Abstract][Full Text] [Related]
10. Bridge with a left ventricular assist device to a simultaneous heart and kidney transplant: Review of the United Network for Organ Sharing database.
Gaffey AC; Chen CW; Chung J; Grandin EW; Porrett PM; Acker MA; Atluri P
J Card Surg; 2017 Mar; 32(3):209-214. PubMed ID: 28176387
[TBL] [Abstract][Full Text] [Related]
11. The impact of infection among left ventricular assist device recipients on post-transplantation outcomes: A retrospective review.
Lerman DT; Hamilton KW; Byrne D; Lee DF; Zeitler K; Claridge T; Gray J; Minamoto GY
Transpl Infect Dis; 2018 Dec; 20(6):e12995. PubMed ID: 30199584
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in eligibility for advanced heart failure therapies.
Steinberg RS; Nayak A; O'Connell C; Burford S; Pekarek A; Chesnut N; Cole RT; Gupta D; Laskar SR; Bhatt K; Burke M; Attia T; Smith A; Vega JD; Morris AA
Clin Transplant; 2020 May; 34(5):e13839. PubMed ID: 32073188
[TBL] [Abstract][Full Text] [Related]
13. Effects of Systemic and Device-Related Complications in Patients Bridged to Transplantation With Left Ventricular Assist Devices.
Lui C; Suarez-Pierre A; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
J Surg Res; 2020 Feb; 246():207-212. PubMed ID: 31605947
[TBL] [Abstract][Full Text] [Related]
14. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
[TBL] [Abstract][Full Text] [Related]
15. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
[TBL] [Abstract][Full Text] [Related]
16. Rescuing Patients With Severe Biventricular Failure in the Era of Continuous-Flow Left Ventricular Assist Device.
Saito S; Toda K; Nakamura T; Miyagawa S; Yoshikawa Y; Hata H; Yoshioka D; Kainuma S; Yoshida S; Sawa Y
Circ J; 2019 Jan; 83(2):379-385. PubMed ID: 30531119
[TBL] [Abstract][Full Text] [Related]
17. National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States.
Wever-Pinzon O; Naka Y; Garan AR; Takeda K; Pan S; Takayama H; Mancini DM; Colombo P; Topkara VK
J Heart Lung Transplant; 2016 Jul; 35(7):884-92. PubMed ID: 27151597
[TBL] [Abstract][Full Text] [Related]
18. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
